Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:The FDA might have no choice...

Hi wildbird1 - If TLD1433 is approved for the treatment of BCG-unresponsive...

March 20, 2022

V.TLT

12 month CR rate of ImmunityBio's N-803 in NMIBC trial

N-803 attained a CR rate at any time of 72%, but there was only a 59...

March 19, 2022

V.TLT

RE:The FDA might have no choice...

Hi wildbird1 -  the competition is not doing nearly as well as you wrote...

March 19, 2022

V.TLT

March 14 audio interview with Dr. McFarland

The audio interview with Dr. McFarland is now working.   https...

March 16, 2022

V.TLT

RE:RE:RE:RE:RE:« interim analysis » and « successfully treated »

I'm very sorry for your loss Oilminerdeluxe. All the best...

March 16, 2022

V.TLT

New Interview with Dr. McFarland - Fort Worth Report

The audio doesn't seem to be working but the transcript is there This UT...

March 15, 2022

V.TLT

UTA College of Science - Voices Podcast

A segment of the podcast with Dr. McFarland will be recorded live on Tuesday,...

March 13, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:Treated Patients 13 to 30

I'm hoping in 2023 we will see a presentation entitled something like...

March 10, 2022

V.TLT

RE:2022 AUA congress will be held May 13-16, 2022

5 of our 12 principle investigators will be speaking - Drs. Kassouf, Black...

March 10, 2022

V.TLT

RE:RE:RE:There will be no next round of financing

We will have to finish the phase 2 trial no matter what our results. We may...

March 9, 2022

V.TLT

RE:RE:Reading the tea leaves...

If they follow the same pattern as the last 7 newsletters it will be a Monday...

March 8, 2022

V.TLT

Reading the tea leaves...

Theralase has released 7 quarterly newsletters so far. 3 of them were...

March 8, 2022

V.TLT

RE:RE:DJDawg's Visualization Tool

I posted that from my cell and there is no Link quote feature for urls in the...

March 7, 2022

V.TLT

DJDawg's Visualization Tool

Like ScienceFirst posted DJDawg made a great contribution with this table and...

March 7, 2022

V.TLT

RE:RE:Prior to releasing new results

Vindication works too! Oden6570 wrote: LOL Indication !

March 7, 2022

V.TLT

RE:PDT video

Thanks for the link Enrique. That's a great visual introduction for...

March 6, 2022

V.TLT

RE:New news soon!!!!

Tuesday morning would be soon... Legit62 wrote: Got through to customer...

March 4, 2022

V.TLT

New Australian Study Discusses TLD1433

Full text: Photoactive and Luminescent Transition Metal Complexes as...

March 2, 2022

V.TLT

Newsletter Timing

According to the last newsletter 30 phase 2 patients had been treated as of...

March 2, 2022

V.TLT

RE:Regarding quarterly reports

The last update was 3 months ago. https://theralase.com/theralase-releases...

March 1, 2022